| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.31 | 0.08 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |